|
|
|
 |
Search published articles |
 |
|
Showing 2 results for Ghoreishi
Atarod Sadat Mostafavinia, Mohammd Bayat, Mehdi Ghatresamani, Kamran Ghoreishi,
Volume 28, Issue 3 (7-2020)
Abstract
Introduction: Bone formation is disturbed in type 1 diabetes followed by changes in the bone microstructure. The most important metabolic disorder in diabetes is osteoporosis, which is characterized by bone loss and bone structure degradation. This study aimed to determine the effect of low-power laser on bone defect repair in the experimental model of diabetes and osteoporosis.
Materials & Methods: A total of 30 four-month-old female Wistar rats weighing 190-220 g were selected and randomly divided into six groups, including 1: non-diabetic control (Co.), 2: non-diabetic laser (L.), 3: diabetic control (Co.D.), 4: diabetic laser (L.D.), 5: diabetic alendronate (A.D.), and 6: diabetic laser + alendronate (L.A.D.). Diabetes was induced in groups 3, 4, 5, and 6. All groups underwent ovariectomy and partial bone defect. In the laser group, a low-level laser (890nm, 80 Hz, 1/5J / cm 2) was radiated to 3 points at the defect location. Tibia bones were collected, and Real-time PCR was performed after a month. The data were analyzed using ANOVA. A p-value less than P<0.05 was considered statistically significant. Ethics code: 13237-91-1-1393-10397
Findings: The t-test showed a significant decrease in tibia bone density in diabetic and osteoporotic rats, compared to the non-diabetic control group. Moreover, analysis of gene expression data (ANOVA, P<0.05) revealed a significant difference between the group of diabetic laser + alendronate and other groups in terms of Runx2 gene expression and Osteocalcin.
Discussions & Conclusions: According to the findings, laser therapy combined with alendronate can accelerate the repair of partial bone defect in the experimental model of diabetes and osteoporosis.
Fatemeh Ghoreishi, Saqqa Farajtabar Behrestaq, Amir Taghipoor Asrami, Masoumeh Habibian,
Volume 32, Issue 2 (6-2024)
Abstract
Introduction: Consuming a high-fat diet causes obesity, which is one of the hallmarks of metabolic syndrome. The present study aimed to assess the effect of aerobic training and capsaicin supplementation on the expression of lipogenic genes SREBP-1c and FASN in the liver tissue of obese rats
Material & Methods: For this experimental research, 40 eight-week-old male Wistar rats weighing 181.5±2.3 grams were selected as samples. Thereafter, eight rats were fed a normal diet (ND), and 32 rats were fed a high-fat diet (HFD) and randomly assigned to five groups: normal diet, high-fat diet, high-fat diet-training, high-fat diet-capsaicin, and high-fat diet-training-capsaicin. The exercise groups performed an incremental aerobic exercise program (15-25 m/min, 30-60 min/day, five days/week) on a treadmill for eight weeks. Capsaicin (4 mg/kg/day) was taken orally by gavage once a day.
Results: Induction of obesity was associated with increased expression of SREBP-1C (P=0.001) and FASN (P=0.001). It was also revealed that aerobic exercise with capsaicin supplementation significantly decreased SREBP-1C and FASN gene expression in the experimental groups compared to the obese group. Finally, this reduction trend was significant in the combined group compared to the supplement group.
Discussion & Conclusion: It is possible that the use of capsaicin, along with aerobic physical activity, is an effective strategy to neutralize the markers of hepatic lipogenesis.
|
|
